Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

(2021) Gabriel Tayguara Silveira Guerreiro et al.   Hepatology International

MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach

(2021) Tsubasa Tsutsumi et al.   HEPATOLOGY RESEARCH

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

(2019) Myriam Alexander et al.   BMJ-British Medical Journal

Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients

(2018) Yong-ho Lee et al.   JOURNAL OF HEPATOLOGY

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

(2018) Amedeo Lonardo et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan

(2018) Norio Akuta et al.   BMC GASTROENTEROLOGY

Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter

(2018) Hyo Eun Park et al.   JOURNAL OF GASTROENTEROLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

(2017) Vincent Wai-Sun Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

(2016) Paul Y Kwo et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of cardiovascular disease

(2016) Amedeo Lonardo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Editorial: utility and pitfalls of Fatty Liver Index in epidemiologic studies for the diagnosis of NAFLD

(2015) E. Vanni et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)

(2015) Mahmoud Al Rifai et al.   ATHEROSCLEROSIS

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2015) Sumio Watanabe et al.   JOURNAL OF GASTROENTEROLOGY

Local and systemic effects of the multifaceted epicardial adipose tissue depot

(2015) Gianluca Iacobellis   Nature Reviews Endocrinology

Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study

(2014) Kunihiro Nishimura et al.   Journal of Atherosclerosis and Thrombosis

Nonalcoholic fatty liver disease and vascular disease: State-of-the-art

(2014) Silvia Fargion   WORLD JOURNAL OF GASTROENTEROLOGY

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

(2012) Lokpal S. Bhatia et al.   EUROPEAN HEART JOURNAL

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

(2012) Yuichiro Eguchi et al.   JOURNAL OF GASTROENTEROLOGY

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage

(2010) Shinya Kimura et al.   JOURNAL OF EPIDEMIOLOGY

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis

(2009) Koji Fujita et al.   HEPATOLOGY

Trend of Increase in the Incidence of Acute Myocardial Infarction in a Japanese Population: Takashima AMI Registry, 1990-2001

(2008) N. Rumana et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Changes in Coronary Heart Disease Risk Among Japanese

(2008) Hiroyasu Iso   CIRCULATION

Heart Disease in Asia

(2008) Shigetake Sasayama   CIRCULATION